Distorted TCR repertoires define multisystem inflammatory syndrome in children

Amna Malik1, Eszter N Tóth2, Michelle S Teng2

  • 1Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, United Kingdom.

Plos One
|October 27, 2022
PubMed

Insights

Multisystem inflammatory syndrome in children (MIS-C) involves unique T cell receptor (TCR) changes. Children with MIS-C show expanded TRBV11-2 T cells lacking SARS-CoV-2 specificity, distorting their TCR repertoires.

Area of Science:

  • Immunology
  • Virology
  • Pediatrics

Background:

  • Most children infected with SARS-CoV-2 have mild symptoms, but some develop severe multisystem inflammatory syndrome (MIS-C).
  • The underlying immunological mechanisms driving MIS-C severity remain unclear.
  • Understanding T cell receptor (TCR) repertoire alterations may elucidate MIS-C pathogenesis.

Purpose of the Study:

  • To investigate TCR repertoire differences in children with MIS-C compared to those with mild COVID-19.
  • To identify specific T cell populations or TCR features associated with MIS-C.

Main Methods:

  • TCR sequencing was performed on samples from children with MIS-C (n=12) and mild COVID-19 (n=8).
  • TCR repertoires were compared to pre-pandemic controls (n=8) and a large SARS-CoV-2-specific TCR dataset (Adaptive Biotechnologies MIRA).

Main Results:

  • Children with MIS-C exhibited an expansion of TRBV11-2 T cell receptor chains with high junctional and CDR3 diversity.
  • The CDR3 sequences of expanded TRBV11-2 clones in MIS-C patients deviated from known SARS-CoV-2 specific T cell clones.
  • This deviation indicates a distortion of the overall TCR repertoire in MIS-C.

Conclusions:

  • The findings suggest a CDR3-independent expansion of TRBV11-2+ T cells is a hallmark of MIS-C in children.
  • These expanded T cells appear to lack specific recognition of SARS-CoV-2, pointing to a non-specific immune response.
  • This research provides novel insights into the immunobiology of MIS-C.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.3K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
344
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
525
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
214